Randy Soltys

Randy Soltys, PhD, joined Regeneron in 2011 and now serves as Senior Vice President, Drug Safety and Pharmacometrics, where he is responsible for the Toxicology, Pathology, Preclinical PK/PD and Clinical and Quantitative Pharmacology organizations. Prior to joining Regeneron, he held senior leadership positions in Drug Safety Assessment at Genentech and Bristol-Myers Squibb. Dr. Soltys received his BS in Microbiology from Rutgers University and his PhD in Pharmacology/Toxicology jointly from Rutgers and the University of Medicine and Dentistry of New Jersey, and has been board-certified in Toxicology.